This polysomnography report documents a study performed on Lloyd Seabolt, a 52-year old African American male, to treat his previously diagnosed complex sleep apnea. The study found that BIPAP ASV at an EPAP of 8 with a minimum PS of 3 and maximum PS of 15 using a full face mask adequately controlled his complex sleep apnea, as his AHI was less than one event per hour. His sleep efficiency was good with mild fragmentation and insignificant desaturation. It is recommended he continue treatment with these BIPAP ASV settings and be followed up on clinical efficacy, comfort and compliance.
This polysomnography report documents a study performed on Lloyd Seabolt, a 52-year old African American male, to treat his previously diagnosed complex sleep apnea. The study found that BIPAP ASV at an EPAP of 8 with a minimum PS of 3 and maximum PS of 15 using a full face mask adequately controlled his complex sleep apnea, as his AHI was less than one event per hour. His sleep efficiency was good with mild fragmentation and insignificant desaturation. It is recommended he continue treatment with these BIPAP ASV settings and be followed up on clinical efficacy, comfort and compliance.
This polysomnography report documents a study performed on Lloyd Seabolt, a 52-year old African American male, to treat his previously diagnosed complex sleep apnea. The study found that BIPAP ASV at an EPAP of 8 with a minimum PS of 3 and maximum PS of 15 using a full face mask adequately controlled his complex sleep apnea, as his AHI was less than one event per hour. His sleep efficiency was good with mild fragmentation and insignificant desaturation. It is recommended he continue treatment with these BIPAP ASV settings and be followed up on clinical efficacy, comfort and compliance.
Study date: February 7, 2022 Sleep technician: James Williams, RPSGT Scoring technician: James Williams, RPSGT THERAPEUTIC POLYSOMNOGRAPHY WITH BIBAP ASV TITRATION: Overnight polysomnography with BIPAP ASV titration was performed on this patient with previously diagnosed complex sleep apnea. The patient is 52 year old African-American male with a BMI of 23 approximately. His medications include amlodipine, quetiapine, valproic acid, isosorbide, Crestor, insulin, gabapentin, Abilify, and Zaleplon. In the beginning of the study the patient’s waking oxyhemoglobin saturation level in a semi upright position and on BIPAP ASV began at 98%. Thereafter the patient was awake for 34 minutes prior to sleep onset and then achieved a normal sleep efficiency of 90%. Sheep architecture showed normal stage 1 of sleep, elevated stage 2 of sleep, absent slow wave sleep and decreased REM sleep. Latency to REM sleep was normal. In the beginning of the study the patient was started on BIPAP ASV with EPAP 8, PS minimum 3 and PS maximum 15 using full face mask. Review of polysomnographic data shows that no further adjustment of the pressure were required. Sleep efficiency was good. No snoring was heard. Sleep fragmentation was mild. He slept only in the right decubitus position. Insignificant oxyhemoglobin desaturation were noted. Overall AHI was less than one event per hour for this therapeutic study. Periodic limb movements were insignificant. Rhythm was normal sinus. His morning questionnaires stated that he slept worse than usual. DIAGNOSIS: Adequate control of complex sleep apnea with BIPAP ASV, EPAP 8, PS minimum 3 and PS maximum 15 using a full faced mask. COMMENTS: The patient has complex sleep apnea as documented on the previous split night polysomnography form November 20, 2021. With BIPAP ASV there is very good control. It is recommended that the patient be started on the above mentioned settings of BIPAP ASV using a full face mask and followed up clinical efficacy, comfort and compliance. Attention to any sleep hygiene issues was recommended. Thank you for your kind referral.